---
schema_version: "secwatch.filing_event.v1"
accession: "0000096943-22-000088"
form_type: "8-K"
ticker: "TFX"
cik: "0000096943"
company_name: "TELEFLEX INC"
filed_at: "2022-07-28T23:59:59+00:00"
generated_at: "2026-06-24T07:56:04.397965+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Teleflex Q2 revenue $704.5M (-1.3% YoY); FY2022 adjusted EPS guidance cut to $13.00-$13.40 from $13.70-$14.30

## Summary
- Revenue $704.5M, down 1.3% YoY; constant currency growth +2.3%.
- GAAP diluted EPS $2.23 vs $1.76 prior year; adjusted EPS $3.39 vs $3.35.
- Interventional Urology revenue fell 13.5% YoY on constant currency basis.
- FY2022 adjusted EPS guidance lowered to $13.00-$13.40 from $13.70-$14.30.
- Constant currency revenue growth guidance reduced to 3.25%-4.25% from 4.0%-5.5%.

## SEC filing metadata
- accession: 0000096943-22-000088
- form_type: 8-K
- ticker: TFX
- cik: 0000096943
- company_name: TELEFLEX INC
- filed_at: 2022-07-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/96943/000009694322000088/0000096943-22-000088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/96943/000009694322000088/tfx-20220728.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000096943-22-000088
- JSON: https://secwatch.observer/filing/0000096943-22-000088.json
- Plain text: https://secwatch.observer/filing/0000096943-22-000088.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.